Trademarkia Logo

Australia

AU$
KATAMARYN
Accepted: In opposition period

Last updated on 11 Sept 2024

Owner Info

Boston Pharmaceuticals, Inc.

55 Cambridge Parkway, Suite 401

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2456059 filed on 21 Mar 2024

Correspondent

Camille M. Miller Cozen O'Connor

1650 Market Street, Suite 2800,

Philadelphia PA 19103,

UNITED STATES OF AMERICA

KATAMARYN

Classification Information


Class [042]
Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of Read More

Mark Details


Serial Number

2456059

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Oct 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
11th Sept 2024International Registration in Australia Protected After Adverse (No amendments) correspondence sent
10th Sept 2024International Registration in Australia Protected After Adverse (No amendments) correspondence sent
10th Sept 2024IP Right Registration Published
10th Sept 2024Status change to Registered/Protected
4th Jul 2024Application Accepted correspondence sent
3rd Jul 2024Application Accepted correspondence sent
3rd Jul 2024IP Right has been Examined
3rd Jul 2024IP Right Acceptance Published
3rd Jul 2024Status change to Accepted
2th Jul 2024Examination Response Received